annual CFF:
$480.19M+$335.01M(+230.75%)Summary
- As of today (August 18, 2025), ASND annual cash flow from financing activities is $480.19 million, with the most recent change of +$335.01 million (+230.75%) on December 31, 2024.
- During the last 3 years, ASND annual CFF has risen by +$64.86 million (+15.62%).
- ASND annual CFF is now -30.10% below its all-time high of $687.01 million, reached on December 31, 2020.
Performance
ASND Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$6.96M+$25.93M(+136.71%)Summary
- As of today (August 18, 2025), ASND quarterly cash flow from financing activities is $6.96 million, with the most recent change of +$25.93 million (+136.71%) on June 1, 2025.
- Over the past year, ASND quarterly CFF has increased by +$9.71 million (+353.38%).
- ASND quarterly CFF is now -98.94% below its all-time high of $656.32 million, reached on September 30, 2020.
Performance
ASND quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$453.55M+$9.71M(+2.19%)Summary
- As of today (August 18, 2025), ASND TTM cash flow from financing activities is $453.55 million, with the most recent change of +$9.71 million (+2.19%) on June 1, 2025.
- Over the past year, ASND TTM CFF has increased by +$288.81 million (+175.32%).
- ASND TTM CFF is now -47.38% below its all-time high of $861.95 million, reached on March 31, 2022.
Performance
ASND TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ASND Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +230.8% | +353.4% | +175.3% |
| 3 y3 years | +15.6% | +153.6% | -46.5% |
| 5 y5 years | -13.1% | -28.0% | +4174.6% |
ASND Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +230.8% | -98.5% | +136.7% | -46.5% | +1472.0% |
| 5 y | 5-year | -30.1% | +230.8% | -98.9% | +123.5% | -47.4% | +1472.0% |
| alltime | all time | -30.1% | >+9999.0% | -98.9% | +123.5% | -47.4% | +1472.0% |
ASND Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $6.96M(-136.7%) | $453.55M(+2.2%) |
| Mar 2025 | - | -$18.97M(-1081.7%) | $443.84M(-8.1%) |
| Dec 2024 | $480.19M(+230.7%) | $1.93M(-99.6%) | $482.80M(+2.2%) |
| Sep 2024 | - | $463.62M(<-9900.0%) | $472.41M(+186.8%) |
| Jun 2024 | - | -$2.75M(-113.7%) | $164.74M(-0.1%) |
| Mar 2024 | - | $20.00M(-336.4%) | $164.98M(+14.4%) |
| Dec 2023 | $145.19M(-65.2%) | -$8.46M(-105.4%) | $144.23M(-0.9%) |
| Sep 2023 | - | $155.95M(-6314.8%) | $145.58M(-744.6%) |
| Jun 2023 | - | -$2.51M(+233.2%) | -$22.58M(-31.7%) |
| Mar 2023 | - | -$753.20K(-89.4%) | -$33.06M(-108.0%) |
| Dec 2022 | $417.00M(+0.4%) | -$7.11M(-41.8%) | $413.89M(+5.8%) |
| Sep 2022 | - | -$12.21M(-6.0%) | $391.36M(-53.8%) |
| Jun 2022 | - | -$12.98M(-102.9%) | $847.29M(-1.7%) |
| Mar 2022 | - | $446.19M(-1605.5%) | $861.95M(+107.3%) |
| Dec 2021 | $415.33M(-39.5%) | -$29.64M(-106.7%) | $415.78M(-11.1%) |
| Sep 2021 | - | $443.72M(>+9900.0%) | $467.66M(-31.3%) |
| Jun 2021 | - | $1.68M(+6850.6%) | $680.26M(-1.2%) |
| Mar 2021 | - | $24.10K(-99.9%) | $688.26M(+0.2%) |
| Dec 2020 | $687.01M(+24.4%) | $22.24M(-96.6%) | $687.01M(+3.0%) |
| Sep 2020 | - | $656.32M(+6681.0%) | $666.86M(+6185.0%) |
| Jun 2020 | - | $9.68M(-886.5%) | $10.61M(+46.1%) |
| Mar 2020 | - | -$1.23M(-158.8%) | $7.26M(-98.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $552.45M(+130.4%) | $2.09M(+2866.8%) | $552.45M(+0.5%) |
| Sep 2019 | - | $70.50K(-98.9%) | $549.93M(+0.2%) |
| Jun 2019 | - | $6.33M(-98.8%) | $548.93M(+1.1%) |
| Mar 2019 | - | $543.96M(<-9900.0%) | $542.80M(+125.4%) |
| Dec 2018 | $239.80M(+70.5%) | -$430.70K(-53.5%) | $240.84M(-8.4%) |
| Sep 2018 | - | -$926.30K(-569.0%) | $263.06M(-31.2%) |
| Jun 2018 | - | $197.50K(-99.9%) | $382.27M(+0.1%) |
| Mar 2018 | - | $242.00M(+1010.5%) | $382.07M(+171.4%) |
| Dec 2017 | $140.68M(+8.3%) | $21.79M(-81.6%) | $140.76M(-43.5%) |
| Sep 2017 | - | $118.28M(>+9900.0%) | $249.04M(+90.3%) |
| Jun 2017 | - | $3900.00(-99.4%) | $130.89M(-0.4%) |
| Mar 2017 | - | $683.50K(-99.5%) | $131.46M(+0.5%) |
| Dec 2016 | $129.94M(+10.8%) | $130.07M(>+9900.0%) | $130.78M(>+9900.0%) |
| Sep 2016 | - | $137.50K(-76.0%) | $613.10K(+28.9%) |
| Jun 2016 | - | $573.30K(>+9900.0%) | $475.60K(-586.8%) |
| Mar 2016 | - | $0.00(-100.0%) | -$97.70K(0.0%) |
| Dec 2015 | $117.26M(+84.5%) | -$97.70K(-100.2%) | -$97.70K(-100.2%) |
| Dec 2014 | $63.55M(<-9900.0%) | $64.09M(<-9900.0%) | $63.55M(<-9900.0%) |
| Sep 2014 | - | -$547.90K(+631.5%) | -$622.80K(+337.7%) |
| Dec 2013 | -$292.10K(+10.9%) | -$74.90K(+11.1%) | -$142.30K(+111.1%) |
| Sep 2013 | - | -$67.40K | -$67.40K |
| Dec 2012 | -$263.30K | - | - |
FAQ
- What is Ascendis Pharma A/S annual cash flow from financing activities?
- What is the all time high annual CFF for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual CFF year-on-year change?
- What is Ascendis Pharma A/S quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly CFF year-on-year change?
- What is Ascendis Pharma A/S TTM cash flow from financing activities?
- What is the all time high TTM CFF for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S TTM CFF year-on-year change?
What is Ascendis Pharma A/S annual cash flow from financing activities?
The current annual CFF of ASND is $480.19M
What is the all time high annual CFF for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual cash flow from financing activities is $687.01M
What is Ascendis Pharma A/S annual CFF year-on-year change?
Over the past year, ASND annual cash flow from financing activities has changed by +$335.01M (+230.75%)
What is Ascendis Pharma A/S quarterly cash flow from financing activities?
The current quarterly CFF of ASND is $6.96M
What is the all time high quarterly CFF for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly cash flow from financing activities is $656.32M
What is Ascendis Pharma A/S quarterly CFF year-on-year change?
Over the past year, ASND quarterly cash flow from financing activities has changed by +$9.71M (+353.38%)
What is Ascendis Pharma A/S TTM cash flow from financing activities?
The current TTM CFF of ASND is $453.55M
What is the all time high TTM CFF for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high TTM cash flow from financing activities is $861.95M
What is Ascendis Pharma A/S TTM CFF year-on-year change?
Over the past year, ASND TTM cash flow from financing activities has changed by +$288.81M (+175.32%)